OTTAWA (Reuters) - Canada's Supreme Court on Thursday ruled against global drug giant Pfizer Inc, ruling that a patent on its Viagra erectile dysfunction drug was no longer valid.
The court backed an appeal by Israeli-based Teva Pharmaceutical Industries Ltd - the world's largest generic drug maker - which argued Pfizer had not provided enough details when filing its patent, which runs out in 2014 in Canada. (Reporting by David Ljunggren; Editing by Jeffrey Hodgson)
This article is brought to you by DATING ADVICE.
No comments:
Post a Comment